Proto Script Pharmaceutical Corp
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.
Market Cap & Net Worth: Proto Script Pharmaceutical Corp (PSCR)
Proto Script Pharmaceutical Corp (PINK:PSCR) has a market capitalization of $14.74K ($14.74K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #46052 globally and #14397 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Proto Script Pharmaceutical Corp's stock price $0.00 by its total outstanding shares 49139998 (49.14 Million).
Proto Script Pharmaceutical Corp Market Cap History: 2016 to 2025
Proto Script Pharmaceutical Corp's market capitalization history from 2016 to 2025. Data shows change from $46.19 Million to $14.74K (-38.03% CAGR).
Proto Script Pharmaceutical Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Proto Script Pharmaceutical Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
58.55x
Proto Script Pharmaceutical Corp's market cap is 58.55 times its annual revenue
1.20x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $46.19 Million | $788.96K | -$7.18 Million | 58.55x | N/A |
Competitor Companies of PSCR by Market Capitalization
Companies near Proto Script Pharmaceutical Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Proto Script Pharmaceutical Corp by market ranking:
- Cintas Corporation (NASDAQ:CTAS): Ranked #328 globally with a market cap of $65.93 Billion USD.
- Relx PLC (PINK:RLXXF): Ranked #390 globally with a market cap of $56.43 Billion USD.
- Copart Inc (NASDAQ:CPRT): Ranked #683 globally with a market cap of $30.07 Billion USD.
- Thomson Reuters Corp (NYSE:TRI): Ranked #878 globally with a market cap of $22.59 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #328 | Cintas Corporation | NASDAQ:CTAS | $65.93 Billion | $192.84 |
| #390 | Relx PLC | PINK:RLXXF | $56.43 Billion | $48.91 |
| #683 | Copart Inc | NASDAQ:CPRT | $30.07 Billion | $34.05 |
| #878 | Thomson Reuters Corp | NYSE:TRI | $22.59 Billion | $165.98 |
Proto Script Pharmaceutical Corp Historical Marketcap From 2016 to 2025
Between 2016 and today, Proto Script Pharmaceutical Corp's market cap moved from $46.19 Million to $ 14.74K, with a yearly change of -38.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $14.74K | +50.00% |
| 2024 | $9.83K | 0.00% |
| 2023 | $9.83K | -81.82% |
| 2022 | $54.05K | -8.33% |
| 2021 | $58.97K | -33.33% |
| 2020 | $88.45K | +12.50% |
| 2019 | $78.62K | -68.63% |
| 2018 | $250.61K | -87.25% |
| 2017 | $1.97 Million | -95.74% |
| 2016 | $46.19 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Proto Script Pharmaceutical Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.74K USD |
| MoneyControl | $14.74K USD |
| MarketWatch | $14.74K USD |
| marketcap.company | $14.74K USD |
| Reuters | $14.74K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.